Zsuzsanna Bagó-Horváth

机构：Comprehensive Cancer Center Vienna, Breast Center, Austrian Breast & Colorectal Cancer Study Group, Medical University of Vienna · ORCID：0000-0002-8555-7806

发表论文 347 篇 · 总被引 8204 次 · h-index 45

代表论文

• Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) (2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 被引 96)
• Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases (2024 · Neuro-Oncology · 被引 65)
• Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer (2023 · OncoImmunology · 被引 32)
• Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients (2023 · Journal of Experimental & Clinical Cancer Research · 被引 19)
• Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression (2024 · Molecular Oncology · 被引 16)
• 187P Stage I results of a phase II study of datopotamab deruxtecan (DATO-DXd) in triple-negative breast cancer (TNBC) patients (pts) with active brain metastases (TUXEDO-2) (2024 · ESMO Open · 被引 16)